Protocol Ledger

NCT06305780 · Phase II · COMPLETED

RECOVER-AUTONOMIC Platform Protocol

Interventional Phase II clinical trial protocol NCT06305780 sponsored by Kanecia Obie Zimmerman in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-03-11 Enrollment: 381 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06305780
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)381 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06305780
Protocol FieldVerified Registry Value
NCT IdentifierNCT06305780
Consolidated Lead SponsorKanecia Obie Zimmerman
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment381 participants (ACTUAL)
Registered Start Date2024-03-11
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI